目次

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Treatment type
1.2.2. Type
1.2.3. Regional scope
1.2.4. Estimates and forecasts timeline
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. GVR’s internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.4.5. Details of primary research
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives

Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Treatment type outlook
2.2.2. Type outlook
2.2.3. Regional outlook
2.3. Competitive Insights

Chapter 3. Hematuria Treatment Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.2. Market restraint analysis
3.3. Hematuria Treatment Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Technological landscape
3.3.2.3. Economic landscape

Chapter 4. Hematuria Treatment Market: Treatment Type Estimates & Trend Analysis
4.1. Treatment Type Segment Dashboard
4.2. Hematuria Treatment Market: Treatment Type Movement Analysis
4.3. Global Hematuria Treatment Market Size & Trend Analysis, by Treatment Type, 2021 to 2033 (USD Million)
4.3.1. Pharmacotherapy
4.3.1.1. Market estimates and forecasts 2021 to 2033 (USD Million)
4.3.2. Procedural / Interventional Therapies
4.3.2.1. Market estimates and forecasts 2021 to 2033 (USD Million)
4.3.3. Adjunctive / Supportive Therapies
4.3.3.1. Market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 5. Hematuria Treatment Market: Type Estimates & Trend Analysis
5.1. Type Segment Dashboard
5.2. Hematuria Treatment Market: Type Movement Analysis
5.3. Global Hematuria Treatment Market Size & Trend Analysis, by Type, 2021 to 2033 (USD Million)
5.3.1. Branded
5.3.1.1. Market estimates and forecasts 2021 to 2033 (USD Million)
5.3.2. Generic
5.3.2.1. Market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 6. Hematuria Treatment Market: Regional Estimates & Trend Analysis
6.1. Regional Market Dashboard
6.2. Regional Market Share Analysis, 2024 & 2030
6.3. Hematuria Treatment Market by Region: Key Takeaways
6.4. North America
6.4.1. U.S.
6.4.1.1. Key country dynamics
6.4.1.2. Regulatory framework/reimbursement structure
6.4.1.3. Competitive scenario
6.4.1.4. U.S. market estimates and forecasts 2021 to 2033 (USD Million)
6.4.2. Canada
6.4.2.1. Key country dynamics
6.4.2.2. Regulatory framework/reimbursement structure
6.4.2.3. Competitive scenario
6.4.2.4. Canada market estimates and forecasts 2021 to 2033 (USD Million)
6.5. Europe
6.5.1. Germany
6.5.1.1. Key country dynamics
6.5.1.2. Regulatory framework/reimbursement structure
6.5.1.3. Competitive scenario
6.5.1.4. Germany market estimates and forecasts 2021 to 2033 (USD Million)
6.5.2. UK
6.5.2.1. Key country dynamics
6.5.2.2. Regulatory framework/reimbursement structure
6.5.2.3. Competitive scenario
6.5.2.4. UK market estimates and forecasts 2021 to 2033 (USD Million)
6.5.3. France
6.5.3.1. Key country dynamics
6.5.3.2. Regulatory framework/reimbursement structure
6.5.3.3. Competitive scenario
6.5.3.4. France market estimates and forecasts 2021 to 2033 (USD Million)
6.5.4. Italy
6.5.4.1. Key country dynamics
6.5.4.2. Regulatory framework/reimbursement structure
6.5.4.3. Competitive scenario
6.5.4.4. Italy market estimates and forecasts 2021 to 2033 (USD Million)
6.5.5. Spain
6.5.5.1. Key country dynamics
6.5.5.2. Regulatory framework/reimbursement structure
6.5.5.3. Competitive scenario
6.5.5.4. Spain market estimates and forecasts 2021 to 2033 (USD Million)
6.5.6. Denmark
6.5.6.1. Key country dynamics
6.5.6.2. Regulatory framework/reimbursement structure
6.5.6.3. Competitive scenario
6.5.6.4. Denmark market estimates and forecasts 2021 to 2033 (USD Million)
6.5.7. Sweden
6.5.7.1. Key country dynamics
6.5.7.2. Regulatory framework/reimbursement structure
6.5.7.3. Competitive scenario
6.5.7.4. Sweden market estimates and forecasts 2021 to 2033 (USD Million)
6.5.8. Norway
6.5.8.1. Key country dynamics
6.5.8.2. Regulatory framework/reimbursement structure
6.5.8.3. Competitive scenario
6.5.8.4. Norway market estimates and forecasts 2021 to 2033 (USD Million)
6.6. Asia Pacific
6.6.1. Japan
6.6.1.1. Key country dynamics
6.6.1.2. Regulatory framework/reimbursement structure
6.6.1.3. Competitive scenario
6.6.1.4. Japan market estimates and forecasts 2021 to 2033 (USD Million)
6.6.2. China
6.6.2.1. Key country dynamics
6.6.2.2. Regulatory framework/reimbursement structure
6.6.2.3. Competitive scenario
6.6.2.4. China market estimates and forecasts 2021 to 2033 (USD Million)
6.6.3. India
6.6.3.1. Key country dynamics
6.6.3.2. Regulatory framework/reimbursement structure
6.6.3.3. Competitive scenario
6.6.3.4. India market estimates and forecasts 2021 to 2033 (USD Million)
6.6.4. South Korea
6.6.4.1. Key country dynamics
6.6.4.2. Regulatory framework/reimbursement structure
6.6.4.3. Competitive scenario
6.6.4.4. South Korea market estimates and forecasts 2021 to 2033 (USD Million)
6.6.5. Australia
6.6.5.1. Key country dynamics
6.6.5.2. Regulatory framework/reimbursement structure
6.6.5.3. Competitive scenario
6.6.5.4. Australia market estimates and forecasts 2021 to 2033 (USD Million)
6.6.6. Thailand
6.6.6.1. Key country dynamics
6.6.6.2. Regulatory framework/reimbursement structure
6.6.6.3. Competitive scenario
6.6.6.4. Thailand market estimates and forecasts 2021 to 2033 (USD Million)
6.7. Latin America
6.7.1. Brazil
6.7.1.1. Key country dynamics
6.7.1.2. Regulatory framework/reimbursement structure
6.7.1.3. Competitive scenario
6.7.1.4. Brazil market estimates and forecasts 2021 to 2033 (USD Million)
6.7.2. Mexico
6.7.2.1. Key country dynamics
6.7.2.2. Regulatory framework/reimbursement structure
6.7.2.3. Competitive scenario
6.7.2.4. Mexico market estimates and forecasts 2021 to 2033 (USD Million)
6.7.3. Argentina
6.7.3.1. Key country dynamics
6.7.3.2. Regulatory framework/reimbursement structure
6.7.3.3. Competitive scenario
6.7.3.4. Argentina market estimates and forecasts 2021 to 2033 (USD Million)
6.8. MEA
6.8.1. South Africa
6.8.1.1. Key country dynamics
6.8.1.2. Regulatory framework/reimbursement structure
6.8.1.3. Competitive scenario
6.8.1.4. South Africa market estimates and forecasts 2021 to 2033 (USD Million)
6.8.2. Saudi Arabia
6.8.2.1. Key country dynamics
6.8.2.2. Regulatory framework/reimbursement structure
6.8.2.3. Competitive scenario
6.8.2.4. Saudi Arabia market estimates and forecasts 2021 to 2033 (USD Million)
6.8.3. UAE
6.8.3.1. Key country dynamics
6.8.3.2. Regulatory framework/reimbursement structure
6.8.3.3. Competitive scenario
6.8.3.4. UAE market estimates and forecasts 2021 to 2033 (USD Million)
6.8.4. Kuwait
6.8.4.1. Key country dynamics
6.8.4.2. Regulatory framework/reimbursement structure
6.8.4.3. Competitive scenario
6.8.4.4. Kuwait market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 7. Competitive Landscape
7.1. Recent Developments & Impact Analysis, By Key Market Participants
7.2. Company/Competition Categorization
7.3. Vendor Landscape
7.3.1. Key company heat map analysis, 2024
7.4. Company Profiles
7.4.1. AstraZeneca
7.4.1.1. Company overview
7.4.1.2. Financial performance
7.4.1.3. Product benchmarking
7.4.1.4. Strategic initiatives
7.4.2. Bristol-Myers Squibb Company
7.4.2.1. Company overview
7.4.2.2. Financial performance
7.4.2.3. Product benchmarking
7.4.2.4. Strategic initiatives
7.4.3. F. Hoffmann-La Roche Ltd.
7.4.3.1. Company overview
7.4.3.2. Financial performance
7.4.3.3. Product benchmarking
7.4.3.4. Strategic initiatives
7.4.4. Johnson & Johnson and its affiliates
7.4.4.1. Company overview
7.4.4.2. Financial performance
7.4.4.3. Product benchmarking
7.4.4.4. Strategic initiatives
7.4.5. Merck & Co., Inc.
7.4.5.1. Company overview
7.4.5.2. Financial performance
7.4.5.3. Product benchmarking
7.4.5.4. Strategic initiatives
7.4.6. Novartis AG
7.4.6.1. Company overview
7.4.6.2. Financial performance
7.4.6.3. Product benchmarking
7.4.6.4. Strategic initiatives
7.4.7. Pfizer Inc.
7.4.7.1. Company overview
7.4.7.2. Financial performance
7.4.7.3. Product benchmarking
7.4.7.4. Strategic initiatives
7.4.8. Sun Pharmaceutical Industries Ltd.
7.4.8.1. Company overview
7.4.8.2. Financial performance
7.4.8.3. Product benchmarking
7.4.8.4. Strategic initiativesa

List of Tables
Table 1 List of abbreviations
Table 2 Global hematuria treatment market, by region, 2021 - 2033 (USD Million)
Table 3 Global hematuria treatment market, by treatment type, 2021 - 2033 (USD Million)
Table 4 Global hematuria treatment market, by type, 2021 - 2033 (USD Million)
Table 5 North America hematuria treatment market, by country, 2021 - 2033 (USD Million)
Table 6 North America hematuria treatment market, by treatment type, 2021 - 2033 (USD Million)
Table 7 North America hematuria treatment market, by type, 2021 - 2033 (USD Million)
Table 8 U.S. hematuria treatment, by treatment type, 2021 - 2033 (USD Million)
Table 9 U.S. hematuria treatment market, by type, 2021 - 2033 (USD Million)
Table 10 Canada hematuria treatment market, by treatment type, 2021 - 2033 (USD Million)
Table 11 Canada hematuria treatment market, by type, 2021 - 2033 (USD Million)
Table 12 Europe hematuria treatment market, by country, 2021 - 2033 (USD Million)
Table 13 Europe hematuria treatment market, by treatment type, 2021 - 2033 (USD Million)
Table 14 Europe hematuria treatment market, by type, 2021 - 2033 (USD Million)
Table 15 Germany hematuria treatment market, by treatment type, 2021 - 2033 (USD Million)
Table 16 Germany hematuria treatment market, by type, 2021 - 2033 (USD Million)
Table 17 UK hematuria treatment market, by treatment type, 2021 - 2033 (USD Million)
Table 18 UK hematuria treatment market, by drug, 2021 - 2033 (USD Million)
Table 19 France hematuria treatment market, by treatment type, 2021 - 2033 (USD Million)
Table 20 France hematuria treatment market, by type, 2021 - 2033 (USD Million)
Table 21 Italy hematuria treatment market, by treatment type, 2021 - 2033 (USD Million)
Table 22 Italy hematuria treatment market, by type, 2021 - 2033 (USD Million)
Table 23 Spain hematuria treatment market, by treatment type, 2021 - 2033 (USD Million)
Table 24 Spain hematuria treatment market, by type, 2021 - 2033 (USD Million)
Table 25 Denmark hematuria treatment market, by treatment type, 2021 - 2033 (USD Million)
Table 26 Denmark hematuria treatment market, by type, 2021 - 2033 (USD Million)
Table 27 Sweden hematuria treatment market, by treatment type, 2021 - 2033 (USD Million)
Table 28 Sweden hematuria treatment market, by type, 2021 - 2033 (USD Million)
Table 29 Norway hematuria treatment market, by treatment type, 2021 - 2033 (USD Million)
Table 30 Norway hematuria treatment market, by type, 2021 - 2033 (USD Million)
Table 31 Asia Pacific hematuria treatment market, by country, 2021 - 2033 (USD Million)
Table 32 Asia Pacific hematuria treatment market, by treatment type, 2021 - 2033 (USD Million)
Table 33 Asia Pacific hematuria treatment market, by type, 2021 - 2033 (USD Million)
Table 34 Japan hematuria treatment market, by treatment type, 2021 - 2033 (USD Million)
Table 35 Japan hematuria treatment market, by type, 2021 - 2033 (USD Million)
Table 36 China hematuria treatment market, by treatment type, 2021 - 2033 (USD Million)
Table 37 China hematuria treatment market, by type, 2021 - 2033 (USD Million)
Table 38 India hematuria treatment market, by treatment type, 2021 - 2033 (USD Million)
Table 39 India hematuria treatment market, by type, 2021 - 2033 (USD Million)
Table 40 South Korea hematuria treatment market, by treatment type, 2021 - 2033 (USD Million)
Table 41 South Korea hematuria treatment market, by type, 2021 - 2033 (USD Million)
Table 42 Australia hematuria treatment market, by treatment type, 2021 - 2033 (USD Million)
Table 43 Australia hematuria treatment market, by type, 2021 - 2033 (USD Million)
Table 44 Thailand hematuria treatment market, by treatment type, 2021 - 2033 (USD Million)
Table 45 Thailand hematuria treatment market, by type, 2021 - 2033 (USD Million)
Table 46 Latin America hematuria treatment market, by country, 2021 - 2033 (USD Million)
Table 47 Latin America hematuria treatment market, by treatment type, 2021 - 2033 (USD Million)
Table 48 Latin America hematuria treatment market, by type, 2021 - 2033 (USD Million)
Table 49 Brazil hematuria treatment market, by treatment type, 2021 - 2033 (USD Million)
Table 50 Brazil hematuria treatment market, by type, 2021 - 2033 (USD Million)
Table 51 Mexico hematuria treatment market, by treatment type, 2021 - 2033 (USD Million)
Table 52 Mexico hematuria treatment market, by type, 2021 - 2033 (USD Million)
Table 53 Argentina hematuria treatment market, by treatment type, 2021 - 2033 (USD Million)
Table 54 Argentina hematuria treatment market, by type, 2021 - 2033 (USD Million)
Table 55 MEA hematuria treatment market, by country, 2021 - 2033 (USD Million)
Table 56 MEA hematuria treatment market, by treatment type, 2021 - 2033 (USD Million)
Table 57 MEA hematuria treatment market, by type, 2021 - 2033 (USD Million)
Table 58 South Africa hematuria treatment market, by treatment type, 2021 - 2033 (USD Million)
Table 59 South Africa hematuria treatment market, by type, 2021 - 2033 (USD Million)
Table 60 Saudi Arabia hematuria treatment market, by treatment type, 2021 - 2033 (USD Million)
Table 61 Saudi Arabia hematuria treatment market, by type, 2021 - 2033 (USD Million)
Table 62 UAE hematuria treatment market, by treatment type, 2021 - 2033 (USD Million)
Table 63 UAE hematuria treatment market, by type, 2021 - 2033 (USD Million)
Table 64 Kuwait hematuria treatment market, by treatment type, 2021 - 2033 (USD Million)
Table 65 Kuwait hematuria treatment market, by type, 2021 - 2033 (USD Million)

List of Figures
Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Primary interviews
Fig. 5 Market research approaches
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 Hematuria treatment market: market outlook
Fig. 9 Hematuria treatment competitive insights
Fig. 10 Parent market outlook
Fig. 11 Related/ancillary market outlook
Fig. 12 Penetration and growth prospect mapping
Fig. 13 Hematuria treatment market driver impact
Fig. 14 Hematuria treatment market restraint impact
Fig. 15 Hematuria treatment market strategic initiatives analysis
Fig. 16 Hematuria treatment market: treatment type movement analysis
Fig. 17 Hematuria treatment market: treatment type outlook and key takeaways
Fig. 18 Pharmacotherapy market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 19 Procedural /Interventional therapies market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 20 Adjunctive / Supportive therapies market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 21 Hematuria treatment market: type movement analysis
Fig. 22 Hematuria treatment market: type outlook and key takeaways
Fig. 23 Branded market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 24 Generic market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 25 Global hematuria treatment market: Regional movement analysis
Fig. 26 Global hematuria treatment market: Regional outlook and key takeaways
Fig. 27 North America market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 28 U.S. market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 29 Canada market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 30 Europe market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 31 Germany market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 32 UK market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 33 France market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 34 Italy market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 35 Spain market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 36 Denmark market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 37 Sweden market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 38 Norway market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 39 Asia Pacific market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 40 Japan market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 41 China market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 42 India market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 43 South Korea market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 44 Australia market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 45 Thailand market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 46 Latin America market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 47 Brazil market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 48 Mexico market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 49 Argentina market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 50 Middle East and Africa market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 51 South Africa market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 52 Saudi Arabia market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 53 UAE market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 54 Kuwait market estimates and forecasts, 2021 - 2033 (USD Million)